Teleflex Incorporated (TFX) is a publicly traded Healthcare sector company. As of May 20, 2026, TFX trades at $135.19 with a market cap of $5.77B and a P/E ratio of -5.91. TFX moved +1.90% today. Year to date, TFX is +8.61%; over the trailing twelve months it is +6.56%. Its 52-week range spans $100.18 to $249.91. Analyst consensus is buy with an average price target of $145.38. Rallies surfaces TFX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TFX stock?
Recent politician trading activity in TFX includes disclosures from Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
TFX Key Metrics
Key financial metrics for TFX
Metric
Value
Price
$135.19
Market Cap
$5.77B
P/E Ratio
-5.91
EPS
$-22.80
Dividend Yield
0.34%
52-Week High
$249.91
52-Week Low
$100.18
Volume
561.60K
Avg Volume
0
Revenue (TTM)
$2.13B
Net Income
$-1.01B
Gross Margin
55.14%
Congressional Trades in TFX
Rob Bresnahan sale TFX on Feb 25, 2025 (amount: $15.00K).
Recent politician trading activity in TFX includes disclosures from Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in TFX?
Yes. Rallies tracks politician and congressional stock disclosures for TFX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TFX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TFX. It does not provide personalized investment advice.
